As of close of business last night, Kintara Therapeutics Inc’s stock clocked out at $0.10, down -5.47% from its previous closing price of $0.10. In other words, the price has decreased by -$0.0055 from its previous closing price. On the day, 4976688 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of KTRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KTRA now has a Market Capitalization of 3.92M and an Enterprise Value of 13.51M.
Stock Price History:
Over the past 52 weeks, KTRA has reached a high of $5.98, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is 0.1332, while the 200-Day Moving Average is calculated to be 2.3428.
Shares Statistics:
It appears that KTRA traded 10.09M shares on average per day over the past three months and 19.6M shares per day over the past ten days. A total of 39.04M shares are outstanding, with a floating share count of 38.16M. Insiders hold about 2.25% of the company’s shares, while institutions hold 0.62% stake in the company. Shares short for KTRA as of Feb 15, 2024 were 411.08k with a Short Ratio of 0.04, compared to 407.14k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.05% and a Short% of Float of 1.05%.
Earnings Estimates
As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1 analysts recommending between -$0.38 and -$0.38.
